- $3.27bn
- $2.44bn
- $218.71m
Brief: Ideaya Biosciences Announces The Promotion Of Dr. Michael White To President, Research And Development
Brief: Ideaya Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Ideaya Biosciences Inc Reports Results For The Quarter Ended June 30: Earnings Summary
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Toll Brothers, TG Therapeutics, CECO Environmental
U.S. STOCKS ON THE MOVE-Nuvalent, Sirius XM, J.M. Smucker
IDEAYA Biosciences drops on $300 mln equity raise
Brief: Ideaya Announces Pricing Of $300 Million Offering Of Common Stock At $27 Each
IDEAYA Biosciences falls on $300 mln stock sale plans
Brief: Ideaya Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants
Brief: IDEAYA Biosciences Announces Clinical Collaboration With Roche In Mtap-Deleted Ras-Mutant Pancreatic Cancer
Brief: Ideaya Biosciences Inc - Enters Sales Agreement With Jefferies For Common Stock Offering Up To $350 Million - SEC Filing
Brief: Ideaya Biosciences Inc Files For Mixed Shelf Offering, Size Not Disclosed- SEC Filing
IDEAYA Biosciences Q1 net loss widens, misses expectations on higher R&D spends
U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines
U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma
IDEAYA Biosciences surges after eye cancer drug combo improves survival in trial